3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase NA
1
Phase 4
1
Phase 2/3
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Oropharyngeal Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hyperthermia
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
257
Cyclophosphamide
241
Specimen Handling
198
fludarabine
173
Magnetic Resonance Spectroscopy
173
Biopsy
147
Nivolumab
119
Carboplatin
97
Radiotherapy
92
Paclitaxel
85
venetoclax
82
Cisplatin
80
Gemcitabine
79
fludarabine phosphate
78
Injections
68
Ipilimumab
64
Dexamethasone
61
atezolizumab
59
Bevacizumab
58
Cetuximab
57
Radiation
55
Fluorouracil
55
Azacitidine
55
durvalumab
54
Radiosurgery
52
Temozolomide
47
Rituximab
44
Oxaliplatin
44
Irinotecan
43
Docetaxel
43
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Hyperthermia, Induced
×
1 year
×
Clear all
NCT06761937
2025-07-25
TANCA-I
Erasmus Medical Center
Phase 1
Recruiting
30 enrolled